Harvest Partners Announces Acquisition of AxelaCare Holdings, Inc

  Harvest Partners Announces Acquisition of AxelaCare Holdings, Inc

Business Wire

NEW YORK -- April 15, 2013

Harvest Partners, LP (“Harvest”), a New York-based private equity firm, and
the management team of AxelaCare Holdings, Inc. (“AxelaCare” or the “Company”)
have completed the acquisition of the Company from Excellere Partners, a
Denver, CO-based private equity firm. Terms of the transaction were not
disclosed.

Based in Lenexa, Kansas, AxelaCare is a full-service home infusion therapy
provider. Therapies provided range from immune globulin (IG) therapy to
antibiotics and nutrition therapy for patients across the United States. The
Company also provides real value to practitioners, insurers and manufacturers
through its proprietary outcomes management technology called CareLogix that
monitors and measures the efficacy of IG therapy based on real-time outcomes
and therapy response data.

AxelaCare's management team, including CEO Ted Kramm and President Kathee
Kramm, will continue to lead the Company.

“Healthcare is a key area of interest for Harvest and we have been impressed
by AxelaCare’s rapid rise to become the fifth largest provider of IG therapy
in the U.S. in just four years," said Ira Kleinman, Senior Managing Director
at Harvest Partners. “The company’s investment in processes, technology and
people has led to an efficient, scaleable model with opportunity for continued
growth as a larger share of the population seeks access to these vital
services."

"We are pleased to partner with Ted and his team to guide the company's
organic growth as well as to pursue strategic acquisitions that will build on
AxelaCare's success,” added Jay Wilkins, Managing Director at Harvest.

“We are proud of our proprietary technology, CareLogix, which will ensure a
positive patient experience and superior medical outcome in a home setting.
CareLogix has been a key factor in our ability to attract new referral
sources, manufacturers, insurers and patients, and we look forward to further
developing the technology in conjunction with our partners at Harvest," said
Ted Kramm, Chief Executive Officer.

Senior debt was arranged by GE Capital, Ares Capital Corporation and BMO
Capital Markets. Oaktree Capital Management and Northwestern Mutual Capital
provided mezzanine debt financing. Jefferies and White & Case LLP advised
Harvest. Houlihan Lokey and Greenberg Traurig LLP advised the Company.

Ira D. Kleinman (Senior Managing Director), Jay Wilkins (Managing Director)
and Paige Daly (Principal) of Harvest will be joining AxelaCare's Board of
Directors.

About AxelaCare

Founded in 2008, AxelaCare is a leading high-growth technology-enabled
provider of home infusion services for chronic and acute conditions. The
Company, based in Lenexa, Kansas, is the fifth largest and one of the fastest
growing national providers of immune globulin (IG) treatment, supported by its
patient-centric approach and clinical leadership. AxelaCare has leveraged its
expertise to develop CareLogix, an innovative and proprietary outcomes
technology to assess the impact of IG treatment, which helps optimize therapy
management for patients and provides value to practitioners, insurers and
manufacturers.

About Harvest Partners

Founded in 1981, Harvest Partners, LP (www.harvpart.com) is a leading New
York-based private equity investment firm pursuing management buyouts and
recapitalizations of middle market companies in North America. Harvest focuses
on acquiring profitable companies in the business and industrial services,
manufacturing and distribution, healthcare, midstream energy, and consumer
products and retail sectors. This strategy leverages Harvest’s 31 years of
experience in financing organic and acquisition-oriented growth companies.

Contact:

Harvest Partners
Jay Wilkins, 212-599-6300
or
Owen Blicksilver Public Relations
Caroline Luz, 203-656-2829
caroline@blicksilverpr.com
 
Press spacebar to pause and continue. Press esc to stop.